Literature DB >> 12124364

Alpha(1)- and beta-adrenoceptor stimulation differentially activate p38-MAPK and atrial natriuretic peptide production in the perfused amphibian heart.

Ioanna-Katerina S Aggeli1, Catherine Gaitanaki, Antigone Lazou, Isidoros Beis.   

Abstract

We investigated the activation of p38-MAPK by various adrenergic agents in the perfused Rana ridibunda heart. Phenylephrine (50 micromol l(-1)) rapidly induced the differential activation of all three mitogen-activated protein kinase (MAPK) subfamilies (ERK, JNKs and p38-MAPK) in this experimental system. Focusing on p38-MAPK response to phenylephrine, we found that the kinase phosphorylation reached maximal values at 30 s, declining thereafter to basal values at 15 min. p38-MAPK activation by phenylephrine was verified as exclusively alpha(1)-AR-mediated. Furthermore, SB203580 (1 micromol l(-1)) abolished the kinase phosphorylation by phenylephrine. Isoproterenol (50 micromol l(-1)) was also shown to activate p38-MAPK in a time- and temperature-dependent manner. A marked, sustained p38-MAPK activation profile was observed at 25 degrees C, while at 18 degrees C the kinase response to isoproterenol was modest. Isoproterenol effect on p38-MAPK stimulation was beta-AR-mediated. Immunohistochemical studies revealed the enhanced presence of phosphorylated p38-MAPK and atrial natriuretic peptide (ANP) in both phenylephrine- and isoproterenol-stimulated hearts, a reaction completely blocked by the respective specific antagonists, or the specific p38-MAPK inhibitor SB203580. These findings indicate a functional correlation between p38-MAPK activation and ANP accumulation in the perfused amphibian heart.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124364     DOI: 10.1242/jeb.205.16.2387

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  5 in total

1.  Clinically Advanced p38 Inhibitors Suppress DUX4 Expression in Cellular and Animal Models of Facioscapulohumeral Muscular Dystrophy.

Authors:  Jonathan Oliva; Scott Galasinski; Amelia Richey; Amy E Campbell; Marvin J Meyers; Neal Modi; Jun Wen Zhong; Rabi Tawil; Stephen J Tapscott; Francis M Sverdrup
Journal:  J Pharmacol Exp Ther       Date:  2019-06-12       Impact factor: 4.030

2.  Effects of various oxidants and antioxidants on the p38-MAPK signalling pathway in the perfused amphibian heart.

Authors:  Catherine Gaitanaki; Maria Papatriantafyllou; Konstantina Stathopoulou; Isidoros Beis
Journal:  Mol Cell Biochem       Date:  2006-05-20       Impact factor: 3.396

3.  p38 MAP kinase inhibitor reverses stress-induced myocardial dysfunction in vivo.

Authors:  Fangping Chen; Hong Kan; Gerry Hobbs; Mitchell S Finkel
Journal:  J Appl Physiol (1985)       Date:  2009-02-12

4.  Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart.

Authors:  Rosa Mazza; Alfonsina Gattuso; Cinzia Mannarino; Bhawanjit K Brar; Sandra Francesca Barbieri; Bruno Tota; Sushil K Mahata
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-05-09       Impact factor: 4.733

5.  Small molecule-mediated refolding and activation of myosin motor function.

Authors:  Michael B Radke; Manuel H Taft; Britta Stapel; Denise Hilfiker-Kleiner; Matthias Preller; Dietmar J Manstein
Journal:  Elife       Date:  2014-02-11       Impact factor: 8.140

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.